Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,553
Closed -$427K 333
2026
Q1
$427K Sell
3,553
-687
-16% -$79.3K 0.12% 204
2025
Q4
$446K Buy
+4,240
New +$398K 0.12% 219
2025
Q3
Sell
-11,943
Closed -$945K 347
2025
Q2
$945K Buy
11,943
+8,548
+252% +$679K 0.25% 117
2025
Q1
$305K Buy
+3,395
New +$317K 0.08% 175
2024
Q4
Sell
-5,178
Closed -$588K 261
2024
Q3
$588K Buy
+5,178
New +$615K 0.14% 153
2023
Q2
Sell
-8,801
Closed -$936K 214
2023
Q1
$936K Buy
+8,801
New +$950K 0.19% 124
2022
Q3
Sell
-60,579
Closed -$5.48M 132
2022
Q2
$5.48M Sell
60,579
-18,603
-23% -$1.65M 1.18% 25
2022
Q1
$6.35M Buy
+79,182
New +$6.24M 1.03% 25
2020
Q4
Sell
-58,756
Closed -$4.65M 187
2020
Q3
$4.65M Buy
+58,756
New +$4.6M 0.72% 44
2020
Q1
Sell
-90,053
Closed -$7.82M 163
2019
Q4
$7.82M Sell
90,053
-23,901
-21% -$1.96M 0.83% 22
2019
Q3
$9.15M Buy
+113,954
New +$9.13M 0.87% 27
2017
Q2
Sell
-41,656
Closed -$2.53M 341
2017
Q1
$2.53M Buy
+41,656
New +$2.53M 0.11% 136

Other funds holding MRK

WBI Investments's MRK Position: Q2 2026 in Review

WBI Investments sold out of Merck (MRK) in Q2 2026, closing a stake of 3,553 shares — an estimated $427K sold.

WBI Investments first reported a position in MRK in Q1 2017 and held it in 12 quarters. The position peaked at $9.15M in Q3 2019. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • WBI Investments reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • WBI Investments sold 3,553 Merck shares in Q2 2026, an estimated $427K.
  • WBI Investments first reported a position in Merck in Q1 2017 and held it in 12 quarters.
  • WBI Investments's Merck position peaked at $9.15M in Q3 2019.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on WBI Investments's 13F filing for Q2 2026, filed 11 Aug 2026.